|
Español
English
|
Dadun >
Browsing by Author Diez, J. (Javier)
Showing results 177 to 196 of 201
| Issue Date | Title | Author(s) | | 2007 | The inhibitory effect of leptin on angiotensin II-induced vasoconstriction in vascular smooth muscle cells is mediated via a nitric oxide-dependent mechanism | Rodriguez, A. (Amaia); Fortuño, A. (A.); Gomez-Ambrosi, J. (Javier); Zalba, G. (Guillermo); Diez, J. (Javier); Frühbeck, G. (Gema) |
| 2006 | The inhibitory effect of leptin on angiotensin II-induced vasoconstriction is blunted in spontaneously hypertensive rats | Rodriguez, A. (Amaia); Frühbeck, G. (Gema); Gomez-Ambrosi, J. (Javier); Catalan, V. (Victoria); Sainz, N. (Neira); Diez, J. (Javier); Zalba, G. (Guillermo); Fortuño, A. (A.) |
| 2001 | The loop diuretic torasemide interferes with endothelin-1 actions in the aorta of hypertensive rats | Fortuño, A. (A.); Muñiz, P. (Paula); Zalba, G. (Guillermo); Fortuño, M.A. (María Antonia); Diez, J. (Javier) |
| 2008 | The proinflammatory mediator CD40 ligand is increased in the metabolic syndrome and modulated by adiponectin | Natal, C. (Cristina); Restituto, P. (Patricia); Iñigo, C. (Carmen); Colina, I. (Inmaculada); Diez, J. (Javier); Varo, N. (Nerea) |
| 2001 | The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data | Dzau, V.J. (Victor J.); Bernstein, K. (Kenneth); Celermajer, D. (David); Cohen, J. (Jerome); Dahlöf, B. (Björn); Deanfield, J. (John); Diez, J. (Javier); Drexler, H. (Helmut); Ferrari, R. (Roberto); Van-Gilst, W. (Wiek); Hansson, L. (Lennart); Hornig, B. (Burkhard); Husain, A. (Ahsan); Johnston, C. (Colin); Lazar, H. (Harold); Lonn, E. (Eva); Lüscher, T. (Thomas); Mancini, J. (John); Mimran, A. (Albert); Pepine, C. (Carl); Rabelink, T. (Ton); Remme, W. (Willem); Ruilope, L.M. (Luis M.); Ruzicka, M. (Marcel); Schunkert, H. (Heribert); Swedberg, K. (Karl); Unger, T. (Thomas); Vaughan, D. (Douglas); Weber, M. (Michael) |
| 1992 | The stilbene disulfonic acid DIDS stimulates the production of TNF-alpha in human lymphocytes | Qian, C. (Cheng); Diez, J. (Javier); Larrea, E. (Esther); Garciandia, A. (Ana); Arrazola, A. (Arantxa); Civeira, M.P. (María Pilar); Medina, J.F. (Juan Francisco); Prieto, J. (Jesús) |
| 2005 | The use of collagen-derived serum peptides for the clinical assessment of hypertensive heart disease | Lopez, B. (Begoña); Gonzalez, A. (Arantxa); Querejeta, R. (Ramón); Diez, J. (Javier) |
| 1998 | Tissue availability of insulin-like growth factor I is inversely related to insulin resistance in essential hypertension: effects of angiotensin converting enzyme inhibition | Laviades, C. (Concepción); Gil, M.J. (María José); Monreal, I. (Ignacio); Gonzalez, A. (Arantxa); Diez, J. (Javier) |
| 2009 | TORAFIC study protocol: torasemide prolonged release versus furosemide in patients with chronic heart failure | Diez, J. (Javier); Coca, A. (Antonio); De-Teresa, E. (Eduardo); Anguita, M. (Manuel); Castro-Beiras, A. (Alfonso); Conthe, P. (Pedro); Cobo, E. (Erik); Fernandez, E. (Ester) |
| 2002 | Torasemide in chronic heart failure: results of the TORIC study | Cosin, J. (Juan); Diez, J. (Javier) |
| 1999 | Torasemide inhibits angiotensin II-induced vasoconstriction and intracellular calcium increase in the aorta of spontaneously hypertensive rats | Fortuño, A. (A.); Muñiz, P. (Paula); Ravassa, S. (Susana); Rodriguez, J.A. (José Antonio); Fortuño, M.A. (María Antonia); Zalba, G. (Guillermo); Diez, J. (Javier) |
| 2009 | Towards a new paradigm about hypertensive heart disease | Diez, J. (Javier) |
| 2011 | Towards the molecular diagnosis of hypertensive heart disease? | Diez, J. (Javier); Lopez, B. (Begoña); Beaumont, J. (Javier); Gonzalez, A. (Arantxa); Ravassa, S. (Susana) |
| 1995 | Toward the biochemical assessment of myocardial fibrosis in hypertensive patients | Diez, J. (Javier); Laviades, C. (Concepción); Monreal, I. (Ignacio); Gil, M.J. (María José); Panizo, A. (Ángel); Pardo, J. (Javier) |
| 2000 | Transforming growth factor beta in hypertensives with cardiorenal damage | Laviades, C. (Concepción); Varo, N. (Nerea); Diez, J. (Javier) |
| 2002 | Ultrasonic backscatter and diastolic function in hypertensive patients | Maceira, A.M. (Alicia M.); Barba, J. (Joaquín); Beloqui, O. (Óscar); Diez, J. (Javier) |
| 2002 | Ultrasonic Backscatter and Serum Marker of Cardiac Fibrosis in Hypertensives | Maceira, A.M. (Alicia M.); Barba, J. (Joaquín); Varo, N. (Nerea); Beloqui, O. (Óscar); Diez, J. (Javier) |
| 2007 | Upregulation of myocardial Annexin A5 in hypertensive heart disease: association with systolic dysfunction | Ravassa, S. (Susana); Gonzalez, A. (Arantxa); Lopez, B. (Begoña); Beaumont, J. (Javier); Querejeta, R. (Ramón); Larman, M. (Mariano); Diez, J. (Javier) |
| 2005 | Usefulness of plasma cardiotrophin-1 in assessment of left ventricular hypertrophy regression in hypertensive patients | Gonzalez, A. (Arantxa); Lopez, B. (Begoña); Martin-Raymondi, D. (Diego); Lozano, E. (Elisa); Varo, N. (Nerea); Barba, J. (Joaquín); Serrano, M. (Manuel); Diez, J. (Javier) |
| 2001 | Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients | Lopez, B. (Begoña); Querejeta, R. (Ramón); Varo, N. (Nerea); Gonzalez, A. (Arantxa); Larman, M. (Mariano); Martinez-Ubago, J.L. (José L.); Diez, J. (Javier) |
Showing results 177 to 196 of 201
|
